Credit: Owlet. BabySat is expected to be available by prescription later this year. The Food and Drug Administration (FDA) has cleared BabySat ™, a prescription pulse oximetry device for infants that ...
is a senior reporter and author of the Optimizer newsletter. She has more than 13 years of experience reporting on wearables, health tech, and more. Before coming to The Verge, she worked for Gizmodo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback